Levothyroxine Sodium recalls

Levothyroxine Sodium products have been recalled 61 times, most recently on 2 Sep 2026. The recalling company is usually Accord Healthcare. The most common reason is potency & assay.

Total recalls61since 2021

Last 12 months27reported

Class I00% of total

Ongoing58latest 2 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 18 1 0Feb 2 0 4May 1 7 0Aug 0 1 0Nov 0 0 0Feb 0 1 0May 0 13 0Aug 12 0

Severity split

Class I 0 0%Class II 60 98%Class III 1 2%

Why levothyroxine sodium is recalled

Companies

Product types

Thyroid Medication61100%

By year

20262643%
20251626%
20241830%
202112%

Ongoing levothyroxine sodium recalls

58 active

Reported	Class	Recall	Company	Reason	Where
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide

All levothyroxine sodium recalls, newest first

61 total

Reported	Class	Recall	Company	Reason	Where
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
8 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
1 Apr 2026Drug	CLASS II	Levothyroxine Sodium Tablets USP 150 mcg recalled by Macleods Pharma UsaLevothyroxine Sodium	Macleods Pharma USA	Potency & Assay	Nationwide
15 Oct 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
23 Jul 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
23 Jul 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
23 Jul 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.